Humanized antibody specific for tumor necrosis factor-alpha

一种肿瘤坏死因子、人源化抗体的技术，应用在抗体、抗肿瘤药、抗细胞因子/淋巴因子/干扰素免疫球蛋白等方向，能够解决降低体内免疫应答、丧失原始小鼠抗体高度选择性和反应性等问题

Inactive Publication Date: 2008-01-23
YUHAN
View PDF2 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Humanized antibodies prepared by CDR grafting have the advantage of reducing the immune response in vivo (Riechmann et al., Nature, 332:323, 1988; Nakatani et al., Protein Engineering, 7:435, 1994), however, it is often lost High selectivity and reactivity of the original mouse antibody (Carter P., et al., Proc. Natl. Acad. Sci. USA, 89:4285-4289, 1992)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Humanized antibody specific for tumor necrosis factor-alpha
  • Humanized antibody specific for tumor necrosis factor-alpha
  • Humanized antibody specific for tumor necrosis factor-alpha

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Example 1: Construction of genes encoding humanized antibody heavy chain variable regions

[0052] Use the gene encoding the heavy chain variable region of the TNF-α-specific mouse monoclonal antibody TSK114 (deposit number: KCTC10514BP and KCTC 10515BP) as a template and the primer pair of SEQ ID NO: 1 and 14 to carry out PCR to amplify the leader sequence Gene A encoding the heavy chain variable region of the humanized antibody. The amplified PCR product was subjected to electrophoresis on an agarose gel and recovered from the gel using a QIAgel recovery kit (Qiagen, USA).

[0053]The gene A thus obtained was subjected to PCR using the primer pair of SEQ ID NO: 1 and 7 or SEQ ID NO: 6 and 14 to amplify the DNA fragment, and the resulting DNA fragment and the primer pair of SEQ ID NO: 1 and 14 were used for PCR Overlap PCR. The amplified PCR product was cloned by incubating the amplified PCR product with TOPO vector (TOPO TA cloning kit, Invitrogen lnc., USA) at roo...

Embodiment 2

[0062] Example 2: Construction of the full-length heavy chain gene of a humanized antibody and its expression vector

[0063] To construct a gene encoding a humanized full-length heavy chain using the gene encoding a heavy chain variable region inserted into a TNHV2 Hv vector prepared in Example 1, pHAB-HC containing a gene encoding a heavy chain constant region of a human antibody was used (KCTC 10229BP, Korean Patent Publication No. 2004-12266) carrier.

[0064] First, in order to insert the gene TNHV2 encoding the heavy chain variable region of the humanized antibody into the expression vector pHAB-HC, pCR-TNHV2 Hv was treated with Hind III / ApaI (BioLabs, Inc., USA) at 37°C for 2 hours, Electrophoresis was performed on 1.5% agarose gel and stained with ethidium bromide (EtBr), and a gene fragment of about 450 bp was observed.

[0065] And, Hind III / ApaI treatment, electrophoresis and staining were performed on pHAB-HC, and an enzymatic vector fragment of about 6.5 kb was...

Embodiment 3

[0068] Example 3: Construction of genes encoding light chain variable regions of humanized antibodies

[0069] Use the gene encoding the light chain variable region of the mouse monoclonal antibody TSK114 that specifically recognizes TNF-α as a template and the primer pair of SEQ ID NO: 16 and 30 to carry out PCR to amplify the coding light chain containing the leader sequence. Gene A of the variable region. Gene A was subjected to agarose gel electrophoresis and EtBr staining, and recovered from the gel using a QIAgel recovery kit.

[0070] The gene A thus purified was subjected to PCR using the primer pair of SEQ ID NO: 16 and 25 or SEQ ID NO: 24 and 30 to amplify the DNA fragment, and the resulting DNA fragment and the primers of SEQ ID NO: 16 and 30 were used Overlap PCR was performed on . The amplified PCR product was incubated at room temperature for 45 minutes using TOPO vector (TOPO TA cloning kit, Invitrogen lnc., USA), and the cloned vector was transformed into E...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Humanized antibodies specifically binding to hTNF-a are prepared from a mouse monoclonal antibody by the CDR (complementarity determining region) grafting method, and they show an antigen binding affinity similar to the origninal mouse monoclonal antibody and significantly low immunogenicity. Therefore, the humanized antibodies can be effectively used for treating a hTNF-a-related disease such as rheumatoid arthritis, Crohn's disease, psoriatic arthritis, psoriasis, septicemia, asthma, Wegener's granulomatosis, inflammation, and ankylosing spondylitis.

Description

technical field [0001] The invention relates to a specific humanized antibody of human tumor necrosis factor-alpha and a preparation method thereof. Background technique [0002] Human tumor necrosis factor-α (hereinafter referred to as "hTNF-α") is a homotrimer composed of three 17kDa protein subunits (Eck M.J. et al., JBG, 267:2119-2122, 1992; Smith R.A. et al., JBC, 262:6951-6954, 1987). hTNF-α is an inflammatory cytokine secreted by macrophages and monocytes and functions as a signal transmitter in several cellular responses such as necrosis and apoptosis (Beyaert R. et al. , FEBS Lett., 340:9-16, 1994). hTNF-α causes pro-inflammatory responses leading to tissue destruction such as cartilage and bone destruction (Saklatvala, Nature, 322:547-549, 1986)), induces adhesion molecules, induces procoagulant activity in vascular endothelial cells (Pober JS et al ., J. Immunol., 136; 1680-1687, 1986), and increased neutrophil and lymphocyte adhesion (Pober et al., J. Immunol....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/24A61K39/395A61P29/00
CPCC07K16/241C07K2317/565C07K2317/92A61K2039/505C07K2316/96C07K2317/24C07K2317/76A61P1/04A61P11/06A61P17/06A61P19/02A61P29/00A61P31/04A61P35/00A61P37/06C07K16/24C07K16/18
Inventor 柳泰亨宋戊泳金昶硕朴相久罗康仁李秉圭姜熙日
Owner YUHAN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap